The furore over Mylan’s ‘price gouging’ in relation to EpiPen in the US went global, thanks to social media. Daniel Ghinn examines the reaction of healthcare professionals on social media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback